Mazar Andrew Paul

CIK: 0001727393Chief Scientific Officer
OfficerDirector10% Owner

Mazar Andrew Paul is a corporate insider (Chief Scientific Officer) at Monopar Therapeutics (MNPR) filing SEC Form 4 transactions. 28 transactions across 2 companies. Source: SEC EDGAR.

Total Transactions
28
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Apr 2026
Companies
2

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
105,000
Price
$2.49
Value
$261K
Type
Award
Shares
110,346
Price
-
Value
-
Type
Award
Shares
51,046
Price
-
Value
-
Type
Exercise
Shares
1,606
Price
$0.00
Value
$0
Type
Tax Payment
Shares
471
Price
$2.55
Value
$1K
Type
Exercise
Shares
1,606
Price
-
Value
-
Type
Award
Shares
67,251
Price
$0.00
Value
$0
Type
Award
Shares
88,874
Price
$0.00
Value
$0
Type
Exercise
Shares
1,937
Price
$0.00
Value
$0
Type
Tax Payment
Shares
671
Price
$3.21
Value
$2K
Type
Exercise
Shares
1,937
Price
-
Value
-
Type
Exercise
Shares
1,606
Price
$0.00
Value
$0
Type
Tax Payment
Shares
556
Price
$3.21
Value
$2K
Type
Exercise
Shares
1,606
Price
-
Value
-
Type
Exercise
Shares
1,606
Price
$0.00
Value
$0
Type
Tax Payment
Shares
471
Price
$4.87
Value
$2K
Type
Exercise
Shares
1,606
Price
-
Value
-
Type
Exercise
Shares
3,212
Price
$0.00
Value
$0
Type
Tax Payment
Shares
942
Price
$5.89
Value
$6K
Type
Exercise
Shares
3,212
Price
-
Value
-